Innovative Medicines Canada
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Engaging with the Government of British Columbia to advocate for expanding research, investment, and job creation opportunities in British Columbia’s life sciences and research and development ecosystem.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Employment and Training, Finances and Budgets, Health, Hospitals, Science and Technology
|
|
Engaging with the Government of British Columbia to advocate for innovative procurement of medicines within the health system to improve patient outcomes, including approaches that leverage real-world data to assess effectiveness.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Government Procurement, Health, Hospitals
|
|
Engaging with the Government of British Columbia to ensure patient access to innovative medicines, support continued research investment, and encourage federal advocacy on the proposed Patented Medicine Prices Review Board regulatory changes.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade
|
|
Engaging with the Government of British Columbia to ensure recognition of the value of Innovative Medicines in improving patient outcomes, enhancing system efficiency, and fostering economic growth through sustained investment in the drug plan.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Employment and Training, Finances and Budgets, Health, Hospitals, Science and Technology
|